Chinese Pharma Co. Ducks Investor Suit Over Botched Sale
A California federal judge on Tuesday tossed a putative class action brought by shareholders of China-based American Oriental Bioengineering Inc., saying that the board of directors' failure to disclose an unsuccessful...To view the full article, register now.
Already a subscriber? Click here to view full article